Nearly all UK pharmacies are experiencing severe “challenges” supplying pancreatic enzyme replacement therapy (PERT), the National Pharmacy Association (NPA) warned.

A sample survey by the association found that 96% of pharmacies were struggling to obtain Creon ( pancrelipase , Mylan). A further 89% reported difficulties supplying PERT alternatives.

Patients Resorting to Extreme Measures

The ongoing shortage has forced patients to take desperate action, according to the NPA, which said some are rationing existing medication supplies or skipping meals entirely.

One pharmacist described it as the “worst stock shortage” they had ever encountered. Patients report eating only one meal daily, contacting multiple pharmacies for supplies, or travelling more than 30 miles to obtain the medica

See Full Page